ZEB2 and ovarian cancer: Upregulation of the miR-200 family is thought to impede EMT and suppress metastasis by augmenting E-cadherin expression through the direct targeting of ZEB1 and ZEB2. Overexpression of the miR-200 family was also found to inhibit cell mobility significantly in ovarian cancer cells [12].